4-propoxy-phenethylamine | 57224-67-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-propoxy-phenethylamine
• 英文别名: 4-Propoxy-phenaethylamin；2-(4-Propoxyphenyl)ethanamine
• CAS: 57224-67-6
• 化学式: C₁₁H₁₇NO
• mdl: MFCD08448854
• 分子量: 179.262
• InChiKey: SZJABXMYJCXZGW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-propoxy-phenethylamine 在 硫酸 作用下， 以 甲醇 、 溶剂黄146 为溶剂， 反应 35.0h， 生成 2,4(1H,3H)-Pyrimidinedione, dihydro-1-(2-(4-propoxyphenyl)ethyl)-
  参考文献：
  名称：

  Pyrimidines LIX. Synthesis and biological properties of N-substituted dihydrouracils and dihydrothiouracils

  摘要：

  DOI：

  10.1007/bf00765024
• 作为产物：
  描述：

  p-(n-Propyloxy)-benzylcyanid 在 氨 、 镍 作用下， 生成 4-propoxy-phenethylamine
  参考文献：
  名称：

  Über einige β-Piperidinopropionsäureamide mit anästhetischer Wirkung

  摘要：

  DOI：

  10.1002/ardp.19562890207

文献信息

• [EN] PROPENAMIDE THIOPHENE DERIVATIVES AS FLAVIVIRUS INHIBITORS AND THEIR USE<br/>[FR] DÉRIVÉS DE THIOPHÈNE PROPÉNAMIDE UTILISÉS COMME INHIBITEURS DE FLAVIVIRUS ET LEUR UTILISATION
  申请人：UNIV D'AIX-MARSEILLE

  公开号：WO2017102014A1

  公开（公告）日：2017-06-22

  The present invention deals with new flavivirus inhibitors, compositions comprising said inhibitors and methods for the treatment of disorders related to a viral infection, such as a disease due to a flavivirus infection, comprising administering said inhibitors.

  本发明涉及新的黄病毒抑制剂，包括所述抑制剂的组合物和用于治疗与病毒感染有关的疾病的方法，例如由于黄病毒感染引起的疾病，包括给予所述抑制剂。
• Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same
  申请人：Yuhan Corporation

  公开号：US10383859B2

  公开（公告）日：2019-08-20

  The present invention provides a benzo[d]thiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The benzo[d]thiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the benzo[d]thiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.

  本发明提供了一种苯并[d]噻唑衍生物或其药学上可接受的盐、其制备工艺以及包含其的药物组合物。苯并[d]噻唑衍生物或其药学上可接受的盐可以选择性地抑制 KRS 与层粘连蛋白受体（LR）之间的蛋白-蛋白相互作用，从而抑制癌细胞的迁移。因此，苯并[d]噻唑衍生物或其药学上可接受的盐可用于预防或治疗与癌细胞转移相关的疾病。
• A novel structural class of potent inhibitors of NF-κB activation: structure–activity relationships and biological effects of 6-aminoquinazoline derivatives
  作者：Masanori Tobe、Yoshiaki Isobe、Hideyuki Tomizawa、Takahiro Nagasaki、Hirotada Takahashi、Hideya Hayashi

  DOI：10.1016/s0968-0896(03)00438-3

  日期：2003.9

  In this study, we have investigated the roles of substituents on the terminal phenyl ring at the C(4)-position of the quinazoline core to complete the structure-activity relationships (SARs) of our NF-kappaB activation inhibitors. Among them, compound 12j afforded highly potent inhibitory activity toward NF-kappaB transcriptional activation with IC50 value of 2nM, along with an excellent in vivo efficacy by reducing the edema formation seen in carrageenin-induced inflammation of the rat hind paw. (C) 2003 Elsevier Ltd. All rights reserved.
• BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME
  申请人：Yuhan Corporation

  公开号：EP3483149B1

  公开（公告）日：2021-01-13
• METHOD FOR PRODUCING CYCLOPLATINIZED PLATINUM COMPLEXES, PLATINUM COMPLEXES PRODUCED BY SAID METHOD, AND THE USE THEREOF
  申请人：Englert Ullrich

  公开号：US20100267977A1

  公开（公告）日：2010-10-21

  The present invention relates to a process for preparing cycloplatinated platinum(II) complexes, platinum(II) complexes prepared by this process and the use thereof for the treatment of tumor diseases and/or hemo blastoses.